Skip to main content
. Author manuscript; available in PMC: 2016 Apr 20.
Published in final edited form as: Lancet Neurol. 2014 Jan 22;13(3):276–286. doi: 10.1016/S1474-4422(13)70299-0

Figure 1. Reactivity with brain tissue and neuron cultures of the CSF of patients with GABAAR or GABABR antibodies.

Figure 1

The CSF of patient 2 showed extensive and diffuse immunostaining of the neuropil of cortical and subcortical regions (A; see the appendix for higher magnifications of selected brain regions). This pattern of brain and cerebellar staining is similar to that produced by the CSF of a patient with GABABR antibodies (C). However, patient 2 was negative for GABABR antibodies in a specific cell-based assay (data not shown). These findings suggested the presence of antibodies against a novel neuronal cell-surface antigen, which was confirmed in cultures of live rat hippocampal neurons (B). The CSF of the patient with GABABR antibodies also reacted with the neuronal cell surface, as expected (D). E and F show a similar study using CSF of a control patient without neuronal cell-surface antibodies. In B, D, and F the nucleus of the neurons was counterstained with DAPI. In A, C, and E the tissue was counterstained with haematoxylin.